7.40BMarket Cap-11.12P/E (TTM)
41.240High39.750Low1.25MVolume41.240Open40.720Pre Close50.25MTurnover0.74%Turnover RatioLossP/E (Static)185.91MShares62.40052wk High3.27P/B6.69BFloat Cap29.17052wk Low--Dividend TTM168.21MShs Float62.400Historical High--Div YieldTTM3.66%Amplitude14.080Historical Low40.211Avg Price1Lot Size
Revolution Medicines Stock Forum
Revolutionary KRAS Cancer Drug Achieves 61% Response Rate in Lung Cancer Patients - Key Trial Data Released
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$